Anticoagulation therapy for prevention of pancreatic graft thrombosis: benefits and risks.
Tollemar
J
J
Department of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.
Tydén
G
G
Brattström
C
C
Groth
C G
CG
D003911:Dextrans / Q000009:adverse effects / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006084:Graft Rejection; D006801:Humans; D007683:Kidney Tubular Necrosis, Acute / Q000150:complications; D016035:Pancreas Transplantation; D011183:Postoperative Complications / Q000517:prevention & control*; D013927:Thrombosis / Q000517:prevention & control*; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
D003911:Dextrans; D014859:Warfarin